Koyfin Home > Directory > Health Care > Alexion Pharm Inc > EBITDA / Interest Expenses

Alexion Pharm Inc EBITDA / Interest Expenses Chart (ALXN)

Alexion Pharm Inc annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Alexion Pharm Inc EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $31m a 6.50% increase of 2m year over year
  • Alexion Pharm Inc EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $31m a -3.01% decrease of -1m year over year
  • Alexion Pharm Inc Annual EBITDA / Interest Expenses for 2019 was $32m a 37.15% increase of 12m from 2018
  • Alexion Pharm Inc Annual EBITDA / Interest Expenses for 2018 was $20m a 27.40% increase of 6m from 2017
  • Alexion Pharm Inc Annual EBITDA / Interest Expenses for 2017 was $15m a 18.53% increase of 3m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN EBITDA / Interest Expenses Data

09/2020$31m
06/2020$34m
03/2020$32m
12/2019$29m
09/2019$37m
06/2019$35m
03/2019$30m
12/2018$6m
09/2018$22m
06/2018$21m

Annual ALXN EBITDA / Interest Expenses Data

2019$32m
2018$20m
2017$15m
2016$12m
2015$18m
2014$319m
2013$146m
2012$56m
2011$327m
2010$233m